Advancing Oral Drug Delivery: The Impact of Solid Lipid Nanoparticles on Antiplatelet Therapy

The application of nanoparticle technology in oral medicine has spurred substantial research endeavours to improve the solubility, permeability, and chemical stability of different pharmaceuticals. Improving the bioavailability of poorly absorbed drugs that are significantly degraded in the mouth is a major challenge in this research. The creation of solid lipid nanoparticles (SLNs) is the main topic of this review since it seems like a possible solution to these problems. We go over the stability, characterisation, and synthesis of SLNs, highlighting their potential to improve acute coronary syndrome treatment medication administration. The review also delves into the process by which antiplatelet SLNs work to prevent myocardial infarction, providing information about how they can enhance treatment results.